Feline Toxoplasmosis: Zoonotic Risk, Diagnosis, and Management

Introduction

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. Felids, including domestic cats (Felis catus), serve as the definitive hosts for T. gondii, a role that is central to the parasite's epidemiology and transmission to intermediate hosts, including humans [1, 2]. The parasite's life cycle involves both sexual replication within the feline intestinal epithelium and asexual replication in a wide range of warm-blooded vertebrates [3, 4]. Understanding the biological and biophysical mechanisms of this host-parasite relationship is critical for veterinary diagnostics, risk assessment, and clinical management. This article provides a detailed, publication-grade review of feline toxoplasmosis, with a focus on zoonotic risk, diagnostic methodologies, and therapeutic strategies, specifically addressing concerns related to cat toxoplasmosis baby transmission.

Parasite Biology and Life Cycle in the Definitive Host

Toxoplasma gondii exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within sporulated oocysts) [5]. The feline definitive host becomes infected through the ingestion of tissue cysts containing bradyzoites in raw or undercooked meat, or less commonly, through the ingestion of sporulated oocysts from the environment [2, 6]. Upon ingestion, the cyst wall is digested by proteolytic enzymes in the stomach and small intestine, releasing bradyzoites that invade enterocytes [5].

Within the feline small intestine, bradyzoites undergo a complex developmental program involving multiple rounds of asexual replication (merogony) followed by sexual differentiation (gametogony) [5, 3]. Recent single-cell transcriptomic analyses have elucidated the transcriptional landscape of these pre-sexual and sexual stages, revealing distinct gene expression profiles that govern cell division and differentiation [5, 3]. The sexual cycle culminates in the formation of unsporulated oocysts, which are shed in the feces [3]. A single infected cat can excrete millions of oocysts over a period of one to three weeks [7, 2]. Oocysts sporulate in the environment within one to five days under aerobic conditions, becoming infectious to intermediate hosts [7]. The sporulated oocyst is highly resilient, remaining viable in soil and water for months to years due to its robust outer wall composed of a bilayered structure of proteins and lipids [8].

The entero-epithelial cycle is accompanied by significant changes in the host intestinal microenvironment. MicroRNA (miRNA) expression profiles in the feline small intestine are dynamically altered during T. gondii infection, with specific miRNAs implicated in the regulation of immune responses and cellular proliferation [4]. These molecular changes may influence the efficiency of parasite replication and the duration of oocyst shedding [4].

Zoonotic Risk and Transmission to Humans

The zoonotic potential of T. gondii is a major public health concern, particularly for pregnant women and immunocompromised individuals [9, 10, 11]. Humans are typically infected through three primary routes: ingestion of undercooked meat containing tissue cysts, ingestion of food or water contaminated with sporulated oocysts from cat feces, and congenital transmission from mother to fetus [9, 10, 11]. The risk associated with cat ownership, specifically the concern of cat toxoplasmosis baby transmission, is a frequent topic of inquiry in veterinary practice [11].

Seroprevalence studies in cats demonstrate wide geographic variation. In Hong Kong, seroprevalence in privately-owned cats was reported at 8.5%, while community cats showed a higher rate of 14.7% [1]. In Jordan, seroprevalence reached 41.7% using a commercial ELISA kit, with risk factors including outdoor access and raw meat consumption [2]. In Bangkok, molecular detection of T. gondii DNA in fecal samples from stray cats was 4.5%, indicating active oocyst shedding in a subset of the population [7]. These data underscore the importance of regional epidemiological surveillance.

For pregnant women, the primary risk is primary infection during gestation, which can lead to congenital toxoplasmosis, manifesting as chorioretinitis, intracranial calcifications, hydrocephalus, or fetal death [9, 10]. The risk of vertical transmission increases with gestational age, but the severity of fetal disease is greatest when infection occurs early in pregnancy [9]. Seronegative pregnant women are advised to avoid contact with cat feces, particularly litter boxes, and to practice rigorous hand hygiene after gardening or handling raw meat [11]. Studies on knowledge and practices among pregnant women in various regions, including Côte d'Ivoire and Iraq, reveal significant gaps in awareness regarding transmission routes and preventive measures [10, 12]. Veterinary professionals and students also exhibit variable seroprevalence, reflecting occupational exposure to infected animals [13].

Clinical Signs in Cats

Most T. gondii infections in cats are subclinical [2]. Clinical disease, when it occurs, is most often associated with the extraintestinal asexual replication of tachyzoites in immunocompromised animals, including kittens and cats co-infected with feline immunodeficiency virus (FIV) or feline leukemia virus (FeLV) [14]. The most commonly affected organ systems are the respiratory tract, central nervous system, eyes, and liver [14].

Ocular toxoplasmosis presents as uveitis, chorioretinitis, and retinal detachment [15]. Neurological signs include ataxia, seizures, circling, and behavioral changes, reflecting focal encephalitis or meningoencephalitis [16]. Respiratory signs, such as dyspnea and tachypnea, result from interstitial pneumonia. Hepatic involvement can cause icterus and elevated liver enzymes. In a study of reproductive tissues from cats enrolled in a neutering program, T. gondii DNA was detected in ovarian and uterine tissues, suggesting potential vertical transmission in cats, although this is considered rare [14].

Diagnostic Testing

Accurate diagnosis of feline toxoplasmosis requires a combination of serological, molecular, and histopathological methods. The choice of assay depends on the clinical context, whether the goal is to detect acute infection, chronic infection, or active oocyst shedding.

Serological Assays

Serological detection of anti-T. gondii antibodies (IgG and IgM) is the most common diagnostic approach. The indirect fluorescent antibody test (IFAT) and enzyme-linked immunosorbent assays (ELISAs) are widely used [17, 18, 1, 2]. IgG antibodies indicate prior exposure and chronic infection, while IgM antibodies suggest recent or active infection [17]. However, IgM can persist for months, complicating interpretation.

Recent advances include the development of double-antigen sandwich colloidal gold immunochromatographic strips (ICS) for rapid serological screening across multiple host species [17]. These strips utilize recombinant T. gondii antigens, such as SAG1 (surface antigen 1), to capture antibodies in serum or whole blood [17, 18]. The ICS format provides results within 10-15 minutes and has shown high sensitivity and specificity compared to ELISA [17, 18]. Another promising serological marker is MIC17A, a microneme protein that is expressed during both entero-epithelial and chronic stages, offering potential for detecting infection in cats regardless of shedding status [19].

Molecular Assays

Polymerase chain reaction (PCR) assays are used to detect T. gondii DNA in biological samples, including blood, aqueous humor, cerebrospinal fluid, and feces [7, 20]. Conventional PCR targets the B1 gene or the 529 bp repetitive element, which is present in multiple copies per genome, enhancing sensitivity [7, 20]. An antisense PCR assay has been developed specifically for domestic cats, demonstrating improved specificity by targeting unique regions of the T. gondii genome [20]. Real-time quantitative PCR (qPCR) allows for quantification of parasite burden, which can be useful for monitoring treatment response.

For detection of oocyst shedding, PCR on fecal samples is more sensitive than microscopic examination, but it cannot distinguish between sporulated and unsporulated oocysts [7]. Molecular genotyping of isolates can provide epidemiological data on circulating strains [6].

Histopathology and Immunohistochemistry

Tissue biopsy or necropsy samples can be examined histologically for the presence of tachyzoites or tissue cysts. Immunohistochemistry using anti-T. gondii antibodies enhances detection sensitivity and specificity [21]. This method is particularly valuable for confirming infection in aborted fetuses or in cases with atypical clinical presentations [22, 21].

Diagnostic Algorithm

The following Mermaid diagram outlines a diagnostic decision tree for a cat presenting with suspected toxoplasmosis.

flowchart TD
    A[Cat with clinical signs consistent with toxoplasmosis], > B{Serological testing}
    B, > C[IgG negative, IgM negative]
    C, > D[No evidence of infection. Consider other differentials.]
    B, > E[IgG positive, IgM negative]
    E, > F[Chronic infection. Clinical signs likely due to other causes. Consider PCR if signs persist.]
    B, > G[IgG positive, IgM positive]
    G, > H[Recent or active infection. Proceed to molecular testing.]
    H, > I{PCR on blood, CSF, or aqueous humor}
    I, > J[PCR positive]
    J, > K[Confirm active toxoplasmosis. Initiate treatment.]
    I, > L[PCR negative]
    L, > M[Possible recent infection with low parasitemia. Repeat serology in 2-4 weeks.]
    B, > N[IgG negative, IgM positive]
    N, > O[Possible early acute infection. Repeat serology in 2-4 weeks to confirm seroconversion.]
    O, > P[If clinical signs severe, consider PCR and empirical treatment.]

Treatment Options

Treatment of clinical feline toxoplasmosis is aimed at inhibiting the replication of tachyzoites. The standard therapeutic regimen consists of a combination of clindamycin (a lincosamide antibiotic) and either pyrimethamine (a dihydrofolate reductase inhibitor) or trimethoprim-sulfonamide combinations [14]. Clindamycin is administered at 10-12 mg/kg orally every 12 hours for 4 weeks. Pyrimethamine is given at 0.25-0.5 mg/kg orally every 24 hours, often in combination with a sulfonamide such as sulfadiazine. Folinic acid (leucovorin) is frequently co-administered to prevent bone marrow suppression associated with pyrimethamine.

For ocular toxoplasmosis, topical corticosteroids may be used to control inflammation, but systemic antiparasitic therapy is essential. In cases of severe neurological or respiratory disease, supportive care including fluid therapy, nutritional support, and anticonvulsants may be required.

It is important to note that treatment does not eliminate tissue cysts (bradyzoites), and cats may remain latently infected for life. Therefore, treatment is focused on resolving clinical signs and reducing parasite burden during the acute phase.

Preventive Measures for Zoonotic Risk

Prevention of zoonotic transmission, particularly the risk of cat toxoplasmosis baby infection, requires a multi-faceted approach targeting both the feline host and human behavior.

Management of the Feline Host

1. Indoor confinement: Keeping cats indoors reduces their exposure to infected prey (rodents and birds) and contaminated soil [1, 2].
2. Dietary management: Feeding commercially processed, cooked, or canned cat food eliminates the risk of ingesting tissue cysts from raw meat [2].
3. Litter box hygiene: Litter boxes should be cleaned daily, as oocysts require 1-5 days to sporulate and become infectious. Pregnant women should avoid handling litter boxes. If unavoidable, disposable gloves and thorough hand washing are mandatory [11].
4. Preventing stray cat populations: Trap-neuter-return (TNR) programs can reduce the population of free-roaming cats and thus environmental contamination with oocysts [7].

Human Behavioral Measures

1. Hand hygiene: Washing hands thoroughly after handling raw meat, gardening, or contact with cat feces.
2. Food safety: Cooking meat to an internal temperature of at least 67 degrees Celsius to kill tissue cysts. Washing fruits and vegetables before consumption.
3. Avoiding stray cats: Pregnant women should avoid contact with stray or unknown cats.
4. Education: Public health campaigns targeting pregnant women and healthcare providers are essential to improve knowledge of transmission risks [10, 12].

Vaccination

No licensed vaccine for T. gondii is currently available for cats or humans. However, significant research is underway, including the development of gene-edited live-attenuated vaccines and mRNA-based strategies [23, 24]. These approaches aim to induce robust cellular and humoral immunity while minimizing the risk of reversion to virulence [23]. A vaccine for cats could reduce oocyst shedding and thereby decrease environmental contamination, representing a One Health intervention [24].

Conclusion

Feline toxoplasmosis remains a significant zoonotic concern, particularly for pregnant women and immunocompromised individuals. The definitive role of the cat in the T. gondii life cycle necessitates a thorough understanding of parasite biology, diagnostic methodologies, and clinical management. Advances in serological rapid tests, molecular diagnostics, and single-cell transcriptomics have improved our ability to detect and understand infection in cats. Effective prevention relies on a combination of responsible pet ownership, public education, and continued research into vaccine development. Veterinary professionals play a critical role in advising clients on risk mitigation, especially regarding the specific concerns of cat toxoplasmosis baby transmission.

References

[1] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135800/

[2] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741047/

[3] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020723/

[4] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41965856/

[5] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42153709/

[6] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41528989/

[7] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42094705/

[8] Zhu XK, Cong W, Meng QF. Toxoplasma gondii infection in wildlife in China (1985-2024): A systematic review and meta-analysis with machine learning. Prev Vet Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41747478/

[9] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42202767/

[10] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42199683/

[11] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41628830/

[12] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41873025/

[13] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42201205/

[14] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41651631/

[15] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41603939/

[16] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41481062/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[17] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253330/

[18] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42169035/

[19] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41874672/

[20] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724116/

[21] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864556/

[22] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252005/

[23] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252477/

[24] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42188907/

[25] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42330015/

[26] Aziz KJ, Mikaeelb FB, Nasrullah OJ, et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034957/

[27] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020619/

[28] Tsakmakidis I, Moustakidis K, Alvanou MV, et al. Migratory and opportunistic wild and domestic birds, as Toxoplasma gondii carriers. Parasite Epidemiol Control. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41970607/

[29] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41931585/

[30] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41900989/

[31] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41843222/

[32] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41819961/

[33] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741032/

[34] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41643571/

[35] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41597614/